Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 58 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 7576194

    UspA2 nucleic acid of moraxella catarrhalis

    The Board of Regents of the University of Texas System · Granted Aug 18, 2009 · Expires Aug 13, 2029

    granted

  2. US 7572442

    Selected antibody compositions for binding to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  3. US 7572448

    Combined cancer treatment methods using selected antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted

  4. US 7569683

    UspA2 nucleic acid of Moraxella catarrhalis

    The Board of Regents of the University of Texas System · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  5. US 7563446

    Methods and compositions for inducing autoimmunity in the treatment of cancers

    The Board of Regents of the University of Texas System · Granted Jul 21, 2009 · Expires Jul 16, 2029

    granted

  6. US 7556942

    Tumor suppressor designated Hippo

    The Board of Regents of the University of Texas System · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  7. US 7550617

    Compositions and methods for the treatment of renal and cardiovascular disease

    The Board of Regents of the University of Texas System · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  8. US 7550141

    Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Jun 23, 2009 · Expires Jun 18, 2029

    granted

  9. US 7547759

    Induction of tumor immunity by variants of folate binding protein

    The Board of Regents of the University of Texas System · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  10. US 7538129

    Diazonamide A analog

    The Board of Regents of the University of Texas System · Granted May 26, 2009 · Expires May 21, 2029

    granted

  11. US 7528133

    Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation

    The Board of Regents of the University of Texas System · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  12. US 7524490

    Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site

    The Board of Regents of the University of Texas System · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  13. US 7517895

    Synthetic diazonamides

    The Board of Regents of the University of Texas System · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  14. US 7514095

    Fabrication of drug loaded biodegradable polymer fibers

    The Board of Regents of the University of Texas System · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  15. US 7511124

    Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  16. US 7507716

    Method for treating pain with prolactin antagonists

    The Board of Regents of the University of Texas System · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted

  17. US 7479550

    Amyloid β gene vaccines

    The Board of Regents of the University of Texas System · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  18. US 7473772

    Chimeric GB virus B (GBV-B)

    The Board of Regents of the University of Texas System · Granted Jan 6, 2009 · Expires Jan 1, 2029

    granted

  19. US 7468379

    Inhibition of osteolytic lesions by SRC kinase inhibitors

    The Board of Regents of the University of Texas System · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  20. US 7455833

    Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted

  21. US 7452971

    Compositions and methods for modifying toxic effects of proteinaceous compounds

    The Board of Regents of the University of Texas System · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted

  22. US 7452964

    Compositions and methods of use of targeting peptides against placenta and adipose tissues

    The Board of Regents of the University of Texas System · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted

  23. US 7446182

    Recombinant antibodies for the detection and neutralization of anthrax toxin

    The Board of Regents of the University of Texas System · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted

  24. US 7435755

    CDDO-compounds and combination therapies thereof

    The Board of Regents of the University of Texas System · Granted Oct 14, 2008 · Expires Oct 9, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.